Leen Kawas is a biotech executive and entrepreneur with a Ph.D. in pharmacy. She is the CEO and President of M3 Biotechnology; a company focused on developing treatments for Alzheimer’s and other neurological diseases.
Kawas has made a considerable impact in the field of biotechnology. She has published several papers in peer-reviewed journals, presented at numerous conferences, and been featured in multiple media outlets. Her work has been recognized by the National Institutes of Health (NIH), where she received a prestigious five-year grant to develop treatments for Alzheimer’s disease.
Kawas’s background in pharmacy and biotechnology inspired her to create a company that could make a difference in people’s lives. She co-founded M3 Biotechnology to tackle the challenge of developing effective treatments for neurological diseases, such as Alzheimer’s, which affects millions of people worldwide.
Under Kawas’s leadership, M3 Biotechnology has developed innovative therapies that target the underlying causes of Alzheimer’s disease rather than just treating the symptoms. These treatments have shown promising results in clinical trials and have the potential to revolutionize the field of neurology.
Leen Kawas has received numerous accolades for her work in biotech, including being named one of the Puget Sound Business Journal’s Women of Influence and received the EY Entrepreneur Of The Year® Pacific Northwest Award. She is also a passionate advocate for women in science and entrepreneurship, and she serves as a mentor to young women looking to enter the biotech industry.
In addition to her work with M3 Biotechnology, Leen Kawas is a member of several professional organizations, including the American Association of Pharmaceutical Scientists and the Alzheimer’s Association. She is also a frequent speaker at industry conferences and events, sharing her insights and expertise on the latest developments in the biotech field.
In conclusion, Leen Kawas is a pioneering woman in biotech who has made significant contributions to the field of neurology through her work with M3 Biotechnology. Her innovative treatments have the potential to transform the way we approach Alzheimer’s and other neurological diseases, and her advocacy for women in science and entrepreneurship is inspiring a new generation of biotech leaders.